These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
453 related articles for article (PubMed ID: 16623782)
1. Uterine leiomyoma versus leiomyosarcoma: a new attempt at differential diagnosis based on their cellular characteristics. Watanabe K; Suzuki T Histopathology; 2006 Apr; 48(5):563-8. PubMed ID: 16623782 [TBL] [Abstract][Full Text] [Related]
2. Expression of Ki-67, P53 and progesterone receptors in uterine smooth muscle tumors. Diagnostic value. Petrović D; Babić D; Forko JI; Martinac I Coll Antropol; 2010 Mar; 34(1):93-7. PubMed ID: 20437637 [TBL] [Abstract][Full Text] [Related]
3. Uterine leiomyosarcoma arising in leiomyoma: clinicopathological study of four cases and literature review. Yanai H; Wani Y; Notohara K; Takada S; Yoshino T Pathol Int; 2010 Jul; 60(7):506-9. PubMed ID: 20594271 [TBL] [Abstract][Full Text] [Related]
4. Evaluation of biological potential of smooth muscle tumours. Miettinen M; Fetsch JF Histopathology; 2006 Jan; 48(1):97-105. PubMed ID: 16359541 [TBL] [Abstract][Full Text] [Related]
5. Bcl-2 receptor expression in patients with uterine smooth muscle tumors: an immunohistochemical analysis comparing leiomyoma, uterine smooth muscle tumor of uncertain malignant potential, and leiomyosarcoma. Bodner K; Bodner-Adler B; Kimberger O; Czerwenka K; Mayerhofer K J Soc Gynecol Investig; 2004 Apr; 11(3):187-91. PubMed ID: 15051039 [TBL] [Abstract][Full Text] [Related]
6. Differential Immunoreactivity of p16 in leiomyosarcomas and leiomyoma variants. Gannon BR; Manduch M; Childs TJ Int J Gynecol Pathol; 2008 Jan; 27(1):68-73. PubMed ID: 18156978 [TBL] [Abstract][Full Text] [Related]
7. Tissue microarray immunohistochemical expression of estrogen, progesterone, and androgen receptors in uterine leiomyomata and leiomyosarcoma. Leitao MM; Soslow RA; Nonaka D; Olshen AB; Aghajanian C; Sabbatini P; Dupont J; Hensley M; Sonoda Y; Barakat RR; Anderson S Cancer; 2004 Sep; 101(6):1455-62. PubMed ID: 15316901 [TBL] [Abstract][Full Text] [Related]
8. Estrogen and progesterone receptor expression in patients with uterine smooth muscle tumors. Bodner K; Bodner-Adler B; Kimberger O; Czerwenka K; Mayerhofer K Fertil Steril; 2004 Apr; 81(4):1062-6. PubMed ID: 15066464 [TBL] [Abstract][Full Text] [Related]
9. Expression of thrombospondin 1 (TSP 1) in patients with uterine smooth muscle tumors: an immunohistochemical study. Bodner-Adler B; Nather A; Bodner K; Czerwenka K; Kimberger O; Leodolter S; Mayerhofer K Gynecol Oncol; 2006 Oct; 103(1):186-9. PubMed ID: 16595146 [TBL] [Abstract][Full Text] [Related]
10. Expression of p16 protein in patients with uterine smooth muscle tumors: an immunohistochemical analysis. Bodner-Adler B; Bodner K; Czerwenka K; Kimberger O; Leodolter S; Mayerhofer K Gynecol Oncol; 2005 Jan; 96(1):62-6. PubMed ID: 15589581 [TBL] [Abstract][Full Text] [Related]
11. The Use of p16 in enhancing the histologic classification of uterine smooth muscle tumors. Atkins KA; Arronte N; Darus CJ; Rice LW Am J Surg Pathol; 2008 Jan; 32(1):98-102. PubMed ID: 18162776 [TBL] [Abstract][Full Text] [Related]
12. Use of X-chromosome inactivation pattern to determine the clonal origins of uterine leiomyoma and leiomyosarcoma. Zhang P; Zhang C; Hao J; Sung CJ; Quddus MR; Steinhoff MM; Lawrence WD Hum Pathol; 2006 Oct; 37(10):1350-6. PubMed ID: 16949924 [TBL] [Abstract][Full Text] [Related]
13. Fascin expression in uterine smooth muscle tumors. Kefeli M; Yildiz L; Kaya FC; Aydin O; Kandemir B Int J Gynecol Pathol; 2009 Jul; 28(4):328-33. PubMed ID: 19483633 [TBL] [Abstract][Full Text] [Related]
14. Smooth muscle tumours of the uterine corpus: a clinicopathologic study with immunohistochemical aspects. Waldmann J; Stachs A; Terpe H; Stropahl G; Makovitzky J Anticancer Res; 2005; 25(3A):1559-65. PubMed ID: 16033061 [TBL] [Abstract][Full Text] [Related]
15. Prognostic value of von Willebrand factor, CD34, CD31, and vascular endothelial growth factor expression in women with uterine leiomyosarcomas. Poncelet C; Fauvet R; Feldmann G; Walker F; Madelenat P; Darai E J Surg Oncol; 2004 May; 86(2):84-90. PubMed ID: 15112250 [TBL] [Abstract][Full Text] [Related]
16. Utility of CD10 in distinguishing between endometrial stromal sarcoma and uterine smooth muscle tumors: an immunohistochemical comparison of 34 cases. Chu PG; Arber DA; Weiss LM; Chang KL Mod Pathol; 2001 May; 14(5):465-71. PubMed ID: 11353058 [TBL] [Abstract][Full Text] [Related]
17. Areas with benign morphologic and immunohistochemical features are associated with some uterine leiomyosarcomas. Mittal K; Joutovsky A Gynecol Oncol; 2007 Feb; 104(2):362-5. PubMed ID: 17011615 [TBL] [Abstract][Full Text] [Related]